Skip to content

Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization (IVF)

Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00788619
Enrollment
2
Registered
2008-11-11
Start date
2009-01-31
Completion date
2009-10-31
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Infertility, Assisted reproductive technology, Nitric oxide

Brief summary

Improvements in In-Vitro Fertilization (IVF) outcomes have largely been due to the generation of excess embryos allowing for multiple embryo transfer. Unfortunately this has also increased the risk of multiple pregnancy with associated maternal and neonatal morbidity and mortality. The investigators believe that the concentration of nitric oxide metabolites measured in the culture medium from the first day of culture can identify the best quality embryos allowing us to transfer a limited number of embryos without compromising the optimum chance for pregnancy.

Interventions

PROCEDURETransfer of embryos on day 3 or day 5 after fertilization.

Subjects will be allocated at random to the two arms. Group 1 will have two embryos transferred on day 3 based on nitric oxide concentration. Group 2 will have two embryos transferred on day 5 based on morphologic criteria.

PROCEDUREDay 5 transfer

Subjects will have embryo transfer on day 5 after fertilization. Selection of embryos to transfer will be based on morphologic criteria.

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 37 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 21-37 * Female * Less than two previous unsuccessful IVF cycles

Exclusion criteria

* Day 3 FSH \>9.9 * Fewer than 8 mature oocytes retrieved * Fewer than 8 normally fertilized embryos on day 2 after fertilization

Design outcomes

Primary

MeasureTime frame
Percentage of subjects with viable pregnancy one month after embryo transfer1 month

Secondary

MeasureTime frame
Percentage of subjects with > 2 viable embryos one month after embryo transfer1 month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026